Literature DB >> 23298125

Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.

Didier Rajon1, Wesley E Bolch, Roger W Howell.   

Abstract

PURPOSE: Previous studies have shown that the mean absorbed dose to a tissue element may not be a suitable quantity for correlating with the biological response of cells in that tissue element. Cell survival can depend strongly on the distribution of radioactivity at the cellular and multicellular levels. Furthermore, when cellular absorbed doses are examined, the cross-dose from neighbor cells can be less radiotoxic than the self-dose component. To better understand how the nonuniformity of activity among cells can affect the dose response, a computer model of a 3D tissue culture was previously constructed and showed that activity distribution among cells is significantly more relevant than the mean absorbed dose for low-energy-electron emitters. The present work greatly expands upon those findings.
METHODS: In the present study, we used this same computer model but restricted the number of labeled cells to a fraction of the whole cell population (50%, 10%, and 1%, respectively). The labeled cells were randomly distributed among the whole cell population.
RESULTS: While the activity distribution is an important factor in determining the tissue response for low-energy-electron emitters, the fraction of labeled cells has an even more pronounced effect on survival response. For all electron energies studied, reducing the percentage of cells labeled significantly increases the surviving fraction of the whole population.
CONCLUSIONS: This study provides abundant information on killing tumor and normal cells under some conditions relevant to targeted radionuclide therapy of isolated tumor cells and micrometastases. The percentage of cells labeled, activity distribution among the labeled cells, and electron energy play key roles in determining their response. Most importantly, and not previously demonstrated, lognormal activity distributions can have a profound impact on the response of the tumor cells even when the radionuclide emits high-energy electrons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23298125      PMCID: PMC3543371          DOI: 10.1118/1.4769409

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  43 in total

1.  Evidence for pronounced bystander effects caused by nonuniform distributions of radioactivity using a novel three-dimensional tissue culture model.

Authors:  A Bishayee; D V Rao; R W Howell
Journal:  Radiat Res       Date:  1999-07       Impact factor: 2.841

2.  Dose-rate effects in biologically targeted radiotherapy.

Authors:  J A O'Donoghue; T E Wheldon
Journal:  Int J Radiat Biol       Date:  1989-11       Impact factor: 2.694

3.  On the equivalent dose for Auger electron emitters.

Authors:  R W Howell; V R Narra; K S Sastry; D V Rao
Journal:  Radiat Res       Date:  1993-04       Impact factor: 2.841

4.  Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments.

Authors:  S M Goddu; R W Howell; D V Rao
Journal:  J Nucl Med       Date:  1994-02       Impact factor: 10.057

Review 5.  Microdosimetric concepts in radioimmunotherapy.

Authors:  J L Humm; J C Roeske; D R Fisher; G T Chen
Journal:  Med Phys       Date:  1993 Mar-Apr       Impact factor: 4.071

Review 6.  Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6.

Authors:  J L Humm; R W Howell; D V Rao
Journal:  Med Phys       Date:  1994-12       Impact factor: 4.071

7.  The influence of tracer localization on the electron dose rate delivered to the cell nucleus.

Authors:  M Faraggi; I Gardin; C de Labriolle-Vaylet; J L Moretti; B D Bok
Journal:  J Nucl Med       Date:  1994-01       Impact factor: 10.057

8.  Biological effect of lead-212 localized in the nucleus of mammalian cells: role of recoil energy in the radiotoxicity of internal alpha-particle emitters.

Authors:  M T Azure; R D Archer; K S Sastry; D V Rao; R W Howell
Journal:  Radiat Res       Date:  1994-11       Impact factor: 2.841

9.  Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides.

Authors:  S M Goddu; D V Rao; R W Howell
Journal:  J Nucl Med       Date:  1994-03       Impact factor: 10.057

10.  Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides.

Authors:  J A O'Donoghue; M Bardiès; T E Wheldon
Journal:  J Nucl Med       Date:  1995-10       Impact factor: 10.057

View more
  3 in total

1.  Cellular Response to Exponentially Increasing and Decreasing Dose Rates: Implications for Treatment Planning in Targeted Radionuclide Therapy.

Authors:  Jay H Solanki; Thomas Tritt; Jordan B Pasternack; Julia J Kim; Calvin N Leung; Jason D Domogauer; Nicholas W Colangelo; Venkat R Narra; Roger W Howell
Journal:  Radiat Res       Date:  2017-05-25       Impact factor: 2.841

2.  Targeted Radionuclide Therapy in Patient-Derived Xenografts Using 177Lu-EB-RGD.

Authors:  Liang Zhao; Haojun Chen; Zhide Guo; Kaili Fu; Lanling Yao; Li Fu; Weixi Guo; Xuejun Wen; Orit Jacobson; Xianzhong Zhang; Long Sun; Hua Wu; Qin Lin; Xiaoyuan Chen
Journal:  Mol Cancer Ther       Date:  2020-08-26       Impact factor: 6.261

3.  Modeling bystander effects that cause growth delay of breast cancer xenografts in bone marrow of mice treated with radium-223.

Authors:  Didier A Rajon; Brian S Canter; Calvin N Leung; Tom A Bäck; J Christopher Fritton; Edouard I Azzam; Roger W Howell
Journal:  Int J Radiat Biol       Date:  2021-07-26       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.